FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 96 filers reported holding FIBROGEN INC in Q2 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $52,292,000 | +16.4% | 2,443,562 | +12.6% | 0.01% | +11.1% |
| Q3 2016 | $44,940,000 | +33.4% | 2,170,992 | +5.7% | 0.01% | +28.6% |
| Q2 2016 | $33,692,000 | -19.1% | 2,053,134 | +5.0% | 0.01% | -30.0% |
| Q1 2016 | $41,649,000 | -28.2% | 1,956,290 | +2.7% | 0.01% | -23.1% |
| Q4 2015 | $58,025,000 | +130.9% | 1,904,333 | +66.1% | 0.01% | +85.7% |
| Q3 2015 | $25,132,000 | -6.2% | 1,146,555 | +0.6% | 0.01% | +16.7% |
| Q2 2015 | $26,790,000 | +260.6% | 1,140,004 | +381.5% | 0.01% | +200.0% |
| Q1 2015 | $7,429,000 | +17.2% | 236,757 | +2.1% | 0.00% | 0.0% |
| Q4 2014 | $6,339,000 | – | 231,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |